|
Chemical substances or preparations may present diverse harmful effects for human health. They are categorised as "CMRs" - at the European level or in other systems. |
|
Carcinogens (C): substances and preparations which, through inhalation, ingestion or skin penetration, may cause cancer or increase its frequency
Mutagens (M): substances and preparations which, through inhalation, ingestion or skin penetration, may produce hereditary genetic defects or increase their frequency
Reproductive toxins (R): substances and preparations which, through inhalation, ingestion or skin penetration, may produce or increase the frequency of non-hereditary harmful effects in offspring or damage reproductive capacities or functions
category 1 CMRs: substances and preparations that are known to be CMR for humans;
category 2 CMRs: substances and preparations for which human exposure to such substances and preparations is strongly suspected to cause or increase the frequency of appearance of the aforementioned CMR effects;
category 3 CMRs: substances and preparations of concern for humans because of the possible CMR effects but for which there is not enough information available to classify these substances and preparations in category 2.
2,370,000 employees are allegedly exposed in their workplace to one or more carcinogenic substances, that is 13.5% of employees. Even if collective protection has been provided, exposure to carcinogenic substances has slightly increased since the last survey carried out in 1994.
Around 186,000 employees (1.1%) are allegedly exposed to mutagenic substances and almost 180,000 (1%) to reproductive toxins. The SUMER survey 2002-2003 also shows that CMR exposure is unequally controlled. For example: 23% of exposure to benzene (except fuel oils), whose role in the emergence of leukaemia has long been established, probably do not have any collective protection at their disposal in theory.
How is Afsset involved?
Specific CMR prevention rules are defined in the French Employment Code (articles R231-56 to R231-56-12). In particular, they require employers to replace these agents as far as this is technically possible by a substance, preparation or procedure which is safe or safer for the health of workers. This rule applies to category 1 and 2 CMRs that have been classified and labelled as such by the producer of the chemical agent or which are listed in annex I of Directive 67/548/EEC.
For example, glycol ethers which are classified as reproductive toxins and sold in France have largely been replaced, even if they still remain in a few industrial applications for which no substitute has been found.
In this context, and in accordance with action 4.9 of the Occupational Health Plan (PST 2005-2009), Afsset received a solicited request on 13 June 2006 from the French Ministry of Employment to carry out research into the substitution of chemical substances that are category 1 and 2 carcinogens, mutagens or reproductive toxins (European Union classification). 
This solicited request, which is in fact a long-term project spanning several years, has two objectives aiming to improve the protection of workers:
Review the efficacy of substituting CMR 1 and 2 substances.
Improve the substitution process of these substances.
For this purpose, the study will be conducted in three stages:
1) Identification of the most problematic CMR substances to be studied first and foremost.
Propose a list of substances to be studied as a priority, particularly from the list of CMR chemical agents and procedures.
2) Investigations, studies and bibliographical research.
Make a list of existing products or procedures, and implementation of complementary studies if necessary.
3) Production of (a) teaching aid(s) for CMR substitution
Produce a computer tool to assist and to raise the awareness of manufacturers.
An educational website dealing with the theme “CMR and substitution” is due to be put online shortly at the following address: enjeux-cmr.fr.
A conference on this theme will also be organised by Afsset in the first half of 2007.
